Business ❯Pharmaceutical Industry ❯Drug Pricing

Market Competition

Insurance Coverage Eli Lilly Generic Medications Telehealth Companies Generic Drugs Patient Impact Supply Chain Issues FDA Regulations Telehealth Services Corporate Interests Investment Opportunities

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

The pharmaceutical giant introduces higher-dose vials and reduces costs to increase affordability for uninsured patients and counter competition.

Trump Repeals Biden-Era Order on Prescription Drug Pricing

FDA Ends Shortage of Tirzepatide, Restricts Compounded Weight-Loss Drugs

Novo Nordisk Urges FDA to Ban Compounded Versions of Ozempic and Wegovy

FDA Reconsiders Ban on Compounded Versions of Eli Lilly's Weight Loss Drug

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations